Consequences of interminority ingroup rejection for group identification and well-being

OBJECTIVES

The rejection-identification model (RIM; Branscombe et al. 1999) suggests group identification mitigates the negative effects of perceived discrimination on psychological well-being. The RIM has not been applied to instances of interminority ingroup rejection-discrimination by one's ingroup toward another of their ingroups (e.g., a gay Black American perceiving racial discrimination within his LGBTQ+ community). We address two questions: (a) do the predicted relationships between constructs in the RIM replicate for interminority ingroup rejection? (b) How does interminority ingroup rejection relate to identification with the discriminating ingroup?

METHODS

We test these questions using structural equation modeling (SEM) on a secondary dataset including respondents (N = 3,300) who identify as members of both a racial and sexual minority.

RESULTS

Our analysis produced two key findings. First, replicating past RIM research, we show that perceived discrimination-whether heterosexist or racist in nature-predicts worse well-being and higher identification with the target group. Furthermore, we demonstrate an indirect effect such that discrimination predicts higher group identification and this is positively related to well-being. Second, the interminority ingroup rejection-identification paths varied as a function of whether discrimination was heterosexist or racist. Greater heterosexism within one's racial community predicted greater racial ingroup identification; however, racism within one's sexual minority community was not a significant predictor of sexual minority group identification.

CONCLUSIONS

We discuss implications of interminority ingroup rejection for people who belong to intersecting minority groups and make recommendations for extending research on this issue. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Modulation of early B lymphopoiesis by interleukin-3

We recently reported that interleukin-3 (IL-3) inhibits B lymphoid lineage expression in methylcellulose culture in a dose-dependent manner. We subsequently used flow cytometric analysis of individual colonies in timed exposure to IL-3 to define more precisely the negative regulatory role of IL-3 in early B lymphopoiesis. When lymphohematopoietic progenitors isolated from 5-fluorouracil (5-FU)-treated mice were cultured in the presence of Steel factor (SF), IL-11, IL-7, and erythropoietin (Epo), B lymphopoiesis appeared to proceed through three stages: lymphohematopoietic proliferation, commitment, and early B lymphoid proliferation. When IL-3 was added to the culture for a 48-hour interval from days 4 to 6 of culture, IL-3 slightly enhanced the formation of pre-B cell colonies. These data appeared to contradict our previous observations that continued exposure to IL-3 from days 0 to 4 or longer severely inhibits B lymphoid potential of the cultured cells. A more frequently timed kinetic observation revealed that in the presence of IL-3 the peak of lymphohematopoietic progenitors was 48 hours earlier but less than one-tenth the number of lymphohematopoietic progenitors in cultures without IL-3. When added to cultures for 48 hours beyond day 6 of culture, IL-3 abrogated the B cell potential of the cultured cells. However, IL-3 failed to negatively modulate B lymphoid progenitors when added on day 14 of culture or later. These observations indicate that IL-3 is a potent negative modulator of the early B lymphopoiesis. IL-3 appears to hasten but suppress the proliferation and commitment of lymphohematopoietic progenitors to B cell lineage. It may also inhibit the proliferation of the progenitors immediately after commitment to B cell lineage.

Lymphohematopoietic progenitors of normal mice

We have identified and characterized the lymphohematopoietic progenitors in the bone marrow of normal mice using a single-step methylcellulose culture assay. Lineage-negative Ly-6A/E (Sca-1)+ progenitors isolated from normal mice were plated in methylcellulose culture containing steel factor (SF), interleukin-7 (IL-7), erythropoietin (Ep), and IL-11. After 16 to 17 days of culture, pre-B-cell-containing multilineage myeloid colonies can be microscopically identified; however, flow-cytometric analysis of individual colonies for B220-positive cells proved superior to in situ microscopic identification of lymphomyeloid colonies. Approximately 10% (6/66) of the mixed colonies without a conspicuous B-cell component had B220-positive cells. The single cell origin of the lymphomyeloid colonies was confirmed by micromanipulation. Although the combination of SF, IL-7, and Ep was sufficient to support formation of lymphomyeloid colonies, addition of IL-11, granulocyte colony-stimulating factor or IL-12 to the combination of SF, IL-7, and Ep increased the number of lymphomyeloid colonies. IL-1 alpha and IL-3 independently inhibited the expression of the B-lymphoid lineage when added to the combination of SF, IL-7, Ep, and IL-11. Approximately four times more lymphohematopoietic progenitors are present in normal mice than in mice treated with 5-fluorouracil.

Periodic carbohydrate replacement during 50 min of high-intensity cycling improves subsequent sprint performance

The purpose of this study was to investigate the effect of 7% carbohydrate-electrolyte (CE) drink on sprint capacity immediately following 50 min of high-intensity cycling. After an overnight 12-hr fast, 8 trained male cyclists performed two 50-min simulated time trials on a Monark stationary cycle ergometer. Subjects consumed either the CE or a flavored water placebo (PL) at 10, 20, 30, and 40 min during the time trial. At the conclusion of each 50-min time trial, subjects immediately performed a Wingate Anaerobic Power Test. Peak power, mean power, and minimum power were significantly higher for the CE trials, whereas mean RPE was significantly lower. Mean heart rate and fatigue index were not different between trials. These results suggest that sprint performance following a high-intensity simulated time trial of only 50 min can be improved with periodic consumption of CE during the ride, particularly following an overnight fast, when liver glycogen is likely to be low. These findings have implications for competitive cycling, where sprint capacity at the conclusion of a race is an important determinant of success.